Dexcom has received CE Mark approval for its G5 continuous glucose monitor for distribution in several European countries. The device...
GlySure Limited has announced that it has secured the CE Mark for the world�s first and only Continuous Intravascular Glucose...
Senseonics Holdings, Inc. announced the FDA has approved its Premarket Approval (PMA) application to market the company's Eversense Continuous Glucose...
Dexcom announces that the FDA has granted a De Novo request for the Dexcom G6 CGM System, the newest generation...
The FDA has approved the G5 Mobile Continuous Glucose Monitoring (CGM) System, from Dexcom, for use in type 1 and...
Senseonics Holdings, Inc. a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring...
AbbVie has launched Vyalev (foslevodopa + foscarbidopa), a continuous subcutaneous infusion for Parkinson’s disease, in Japan on July 26
Intarcia Therapeutic has announced positive top-line results from its 52-week Phase III FREEDOM-2 clinical trial to determine the comparative efficacy...
Dexcom, Inc. a leader in continuous glucose monitoring (CGM), announced that the company has received CE Mark for its Dexcom...
Abbott has announced that the FDA has approved the company's FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM)...